Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Shaanxi University Of Chinese Medicine currently manages 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This active matter is assigned to a distinct examiner, indicating a concentrated prosecution focus for the organization at this stage. The presence of a distinct art unit suggests that the portfolio is currently localized within a specific technical niche at the patent office. Practitioners should note that the current workload is entirely contained within these single points of contact.
Examiner BOECKELMAN, JACOB A is identified as the busiest examiner for the university, handling the 1 pending office action. Because the total number of pending office actions is identical to this examiner's workload, this individual is responsible for the entirety of the university's current active cases. This alignment reflects a direct interaction between the applicant and the examining corps. BOECKELMAN, JACOB A represents the current scope of active examination in the Biotechnology & Pharmaceuticals sector. The university's immediate outcomes depend on the perspective of this specific official.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BOECKELMAN, JACOB A | 1 | 35.2% | +45.6% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18380875 | METHOD FOR EXTRACTING AND PURIFYING TOTAL FLAVONOIDS FROM CARTHAMUS TINCTORIUS L. LEAF (TFFCL), AND USE THEREOF | BOECKELMAN, JACOB A | 1d overdue |
| Art Unit | Apps |
|---|---|
| 1655 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18380875 | METHOD FOR EXTRACTING AND PURIFYING TOTAL FLAVONOIDS FROM CARTHAMUS TINCTORIUS L. LEAF (TFFCL), AND USE THEREOF | BOECKELMAN, JACOB A | 1655 | §103 | Non-Final OA | 1d overdue | Pending | Oct 17, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial